background
franc
previou
studi
focus
specif
health
problem
among
medic
student
internship
abroad
includ
clinic
symptom
suggest
infecti
diseas
acquisit
pathogen
carriag
method
clinic
follow
qpcr
base
respiratori
gastrointestin
vagin
pathogen
carriag
travel
prospect
assess
cohort
medic
student
depart
marseil
franc
result
student
includ
student
report
gastrointestin
respiratori
vagin
symptom
respect
acquisit
rate
enteroaggreg
escherichia
coli
eaec
enteropathogen
e
coli
epec
respect
acquisit
respiratori
virus
low
associ
persist
symptom
bacteri
acquisit
rang
streptococcu
pyogen
haemophilu
influenza
gardnerella
vaginali
atopobium
vagina
acquisit
rate
respect
five
student
molecular
quantif
criteria
bacteri
vaginosi
return
conclus
preliminari
studi
demonstr
besid
known
risk
gastrointestin
respiratori
infect
associ
chang
intestin
respiratori
microbiota
medic
student
abroad
may
also
experi
chang
vagin
microbiota
lead
case
clinic
symptom
acquisit
bacteri
vaginosi
may
asymptomat
french
peopl
undertook
estim
million
trip
french
oversea
territori
mainli
europ
lesser
extent
africa
america
asia
intern
travel
expos
acquisit
pathogen
associ
travel
potenti
risk
commun
hospit
popul
upon
return
whether
symptomat
travel
extens
describ
exampl
among
french
hajj
pilgrim
travel
mecca
saudi
arabia
signific
proport
medic
student
highincom
countri
particip
usual
selforganis
also
arrang
faculti
partnership
commerci
volunt
placement
organ
clinic
elect
abroad
also
known
intern
medic
elect
global
health
elect
elect
typic
last
one
three
month
exampl
work
world
australian
organ
place
medic
student
sinc
destin
may
develop
countri
low
middleincom
countri
becom
popular
destin
intern
medic
elect
gener
clinic
immers
experi
younger
medic
student
may
also
particip
humanitarian
mission
unrel
clinic
activ
addit
clinic
placement
mani
student
add
cultur
side
trip
wilder
adventur
itinerari
health
risk
medic
student
elect
abroad
subject
concern
medic
profess
howev
littl
recent
data
infecti
diseas
among
medic
student
part
studi
abroad
one
australian
survey
student
experienc
sort
health
problem
travel
diarrhoea
common
contract
upper
respiratori
tract
infect
includ
influenza
dutch
studi
student
report
diarrhoea
constip
skin
infect
wound
respiratori
tract
infect
swedish
studi
student
report
diarrhoea
franc
previou
studi
focus
specif
health
problem
among
medic
student
internship
abroad
purpos
studi
investig
preval
clinic
symptom
suggest
infecti
diseas
document
acquisit
pathogen
carriag
among
french
medic
student
undertak
internship
abroad
monocentr
prospect
cohort
survey
conduct
june
august
among
medic
student
faculti
medicin
aix
marseil
univers
franc
plan
undertak
internship
abroad
summer
month
recruit
done
voluntari
basi
vaccin
pretravel
consult
institut
hospitalouniversitair
infect
marseil
univers
medic
campu
particip
ask
sign
written
inform
consent
form
complet
inclus
questionnair
cover
demograph
data
intend
travel
date
destin
histori
chronic
ill
vaccin
statu
follow
consult
record
particip
receiv
advic
regard
prevent
travel
diarrhoea
hand
hygien
safe
food
water
habit
use
person
prevent
measur
insect
bite
mosquito
bed
net
repel
warn
regard
rabi
risk
travel
malariaendem
zone
prescrib
malaria
chemoprophylaxi
particip
invit
selfcollect
throat
nasal
faecal
vagin
sampl
week
preced
departur
week
follow
return
franc
sampl
collect
use
commerci
rigid
cottontip
swab
applic
medic
wire
equip
wiltshir
unit
kingdom
place
viral
transport
media
sigma
wiltshir
unit
kingdom
nasal
sampl
particip
train
insert
swab
one
nostril
cm
pharyng
sampl
particip
introduc
swab
oral
caviti
gentli
rub
tonsillar
pillar
sever
time
rectal
sampl
particip
introduc
swab
rectum
anu
cm
vagin
sampl
particip
place
swab
vagina
cm
avoid
touch
skin
vulva
swab
gentli
rub
inner
wall
sever
time
sampl
return
institut
particip
process
student
also
provid
return
questionnair
address
exact
place
internship
took
place
type
activ
conduct
tourism
travel
countri
internship
period
hous
condit
contact
children
anim
symptom
treatment
stay
influenzalik
ill
ili
defin
associ
cough
sore
throat
subject
fever
diarrhoea
defin
least
three
loos
liquid
stool
per
day
amplifi
intern
dna
extract
control
tiss
previous
describ
dna
extract
semiautom
extract
previous
describ
autom
procedur
use
advanc
xl
qiagen
dna
tissu
kit
qiagen
accord
manufactur
recommend
onestep
simplex
realtim
quantit
rtpcr
amplif
perform
use
multiplex
rna
viru
master
kit
roch
diagnost
adenoviru
rotaviru
noroviru
astroviru
intern
control
phage
realtim
pcr
amplif
carri
use
probe
master
kit
roch
diagnost
accord
manufactur
recommend
mapa
gene
campylobact
jejuni
ipah
gene
shigella
sppeiec
enteroinvas
escherichia
coli
inva
gene
salmonella
spp
gene
enterohemorrhag
e
coli
ehec
eaf
eae
gene
enteropathogen
e
coli
epec
gene
enteroaggreg
e
coli
eaec
gene
tropheryma
whipplei
amplifi
intern
dna
extract
control
tiss
gene
cryptosporidium
parvum
homini
gene
entamoeba
histolytica
giardia
lamblia
use
detect
parasit
two
hundr
microlit
homogenis
vagin
suspens
use
dna
purif
qiaamp
dna
mini
kit
qiagen
use
advanc
xl
qiagen
modifi
describ
elsewher
realtim
pcr
amplif
carri
use
probe
master
kit
roch
diagnost
accord
manufactur
recommend
hypothet
protein
gene
chlamydia
trachomati
fusa
gene
mycoplasma
genitalium
pora
gene
neisseria
gonorrhoea
repeat
sequenc
trichomona
vaginali
ftsi
gene
mycoplasma
homini
gene
atopobium
vagina
gene
gardnerella
vaginali
amplifi
intern
dna
extract
control
tiss
quantit
realtim
pcr
detect
respiratori
gastrointestin
vagin
pathogen
perform
use
thermal
cycl
biorad
hercul
ca
usa
neg
control
pcr
mix
posit
control
dna
bacteri
strain
rna
viral
strain
includ
run
posit
result
bacteria
viru
amplif
defin
cycl
threshold
ct
valu
bacteri
vaginosi
defin
vagina
dna
load
copiesml
ct
andor
g
vaginali
dna
load
copiesml
ct
previous
report
differ
proport
assess
use
chisquar
test
twosid
fisher
exact
test
appropri
acquisit
pathogen
defin
neg
travel
posit
return
internship
abroad
evalu
potenti
acquisit
pathogen
carriag
use
mcnemar
test
compar
preval
travel
use
fisher
exact
test
evalu
relat
preval
pathogen
carriag
return
clinic
symptom
percentag
confid
interv
ci
estim
comparison
carri
use
stata
version
pvalu
consid
statist
signific
protocol
approv
institut
review
board
perform
accord
good
clinic
practic
recommend
declar
helsinki
amend
particip
gave
written
inform
consent
total
student
agre
particip
answer
return
questionnair
student
femal
median
age
year
rang
year
tabl
particip
student
second
year
medic
studi
take
part
nonmed
humanitarian
mission
remain
particip
fourth
year
assign
differ
depart
medicin
surgeri
clinic
train
supplementari
tabl
immunolog
statu
particip
travel
describ
supplementari
tabl
total
vaccin
influenza
invas
pneumococc
infect
major
vaccin
hepat
typhoid
fever
prescrib
antimalari
prophylaxi
four
student
chronic
respiratori
diseas
two
use
longterm
corticosteroid
primari
travel
destin
internship
south
east
asia
south
america
africa
south
asia
north
america
top
primari
destin
countri
vietnam
india
peru
madagascar
tabl
mean
travel
durat
day
day
rang
day
accommod
condit
judg
clean
student
clean
basic
particip
contact
local
children
anim
stay
also
travel
tourist
countri
primari
destin
visit
countri
top
addit
destin
countri
lao
bolivia
cambodia
thailand
argentina
total
student
report
least
one
respiratori
symptom
fig
stay
mean
time
arriv
travel
destin
onset
symptom
day
day
rhiniti
preval
symptom
particip
follow
sore
throat
cough
student
report
febril
respiratori
symptom
ili
five
student
receiv
antibiot
one
hospitalis
respiratori
tract
infect
symptom
persist
respiratori
symptom
upon
return
report
individu
total
individu
provid
respiratori
pair
swab
travel
proport
acquir
virus
bacteria
common
viru
acquir
human
rhinoviru
follow
coronaviru
respiratori
syncyti
viru
bacteri
acquisit
rate
slightli
higher
rang
pyogen
h
influenza
tabl
total
student
report
gastrointestin
symptom
travel
one
follow
return
mean
time
arriv
travel
destin
onset
symptom
day
day
abdomin
pain
diarrhoea
frequent
symptom
preval
respect
follow
nausea
constip
four
student
receiv
antibiot
gastrointestin
symptom
particip
still
symptomat
return
marseil
franc
fig
total
particip
provid
pair
rectal
swab
two
student
acquir
viru
adenoviru
bacteri
acquisit
rate
higher
notabl
eaec
epec
addit
individu
acquir
c
jejuni
g
lamblia
tabl
femal
student
five
report
vagin
symptom
leucorrhoea
stay
one
took
antibiot
purpos
two
student
still
symptomat
return
franc
nightyon
particip
provid
pair
vagin
sampl
particip
acquir
least
one
vagin
microorgan
highest
acquisit
rate
vagina
follow
g
vaginali
tabl
five
student
molecular
criteria
bacteri
vaginosi
return
eighteen
student
report
symptom
stay
includ
symptom
skin
infect
urinari
tract
infect
scratch
allergi
cervic
lymphadenopathi
altitud
sick
otiti
chalazion
migrain
palpebr
oedema
four
student
receiv
antibiot
symptom
preval
least
one
respiratori
viru
return
significantli
higher
among
student
persist
respiratori
symptom
upon
return
versu
among
asymptomat
student
among
student
present
respiratori
symptom
stay
recov
return
p
supplementari
tabl
found
signific
associ
tabl
five
student
report
vagin
symptom
one
posit
vagina
g
vaginali
return
molecular
criteria
bacteri
vaginosi
second
year
medic
student
franc
femal
accord
data
aix
marseil
faculti
medicin
student
femal
second
fourth
year
respect
studi
femal
student
account
particip
consist
previou
studi
show
femal
particip
studi
abroad
programm
male
proport
femal
among
student
particip
elect
abroad
given
young
age
particip
preval
chronic
diseas
low
durat
stay
abroad
rang
recent
studi
conduct
medic
student
frequent
destin
develop
countri
includ
vietnam
india
peru
student
took
part
longterm
humanitarian
mission
includ
rel
remot
area
poor
sanitari
condit
immers
local
popul
frequent
contact
children
anim
seven
student
ten
report
gastrointestin
symptom
notabl
diarrhoea
abdomin
pain
nauseavomit
suggest
gastroenter
result
line
studi
conduct
medic
student
abroad
confirm
despit
reinforc
pretravel
advic
travel
diarrhoea
highli
frequent
among
medic
student
fulli
awar
mean
prevent
larg
fiveyear
studi
conduct
among
european
travel
pretravel
advic
associ
lower
rate
travel
diarrhoea
suggest
current
prevent
strategi
revis
observ
low
rate
eaec
rel
high
rate
epec
carriag
asymptomat
student
travel
mark
contrast
recent
find
describ
rate
pretravel
stool
finish
travel
use
valid
qpcr
multiplex
assay
high
rate
eaec
epec
also
observ
asymptomat
hajj
pilgrim
depart
marseil
saudi
arabia
high
rate
epec
asymptomat
medic
student
older
muslim
popul
marseil
baselin
warrant
investig
differ
popul
better
understand
local
epidemiolog
epec
southern
franc
nevertheless
document
dramat
high
acquisit
rate
eaec
epec
among
medic
student
document
recent
studi
conduct
differ
popul
intern
travel
acquisit
e
coli
worri
deserv
investig
aim
evalu
antibiot
resist
bacteria
sinc
one
studi
conduct
medic
student
reveal
acquisit
rate
extendedspectrum
betalactamaseproduc
enterobacteria
found
signific
associ
diarrhoea
e
coli
carriag
studi
contrast
studi
eaec
report
frequent
associ
diarrhoea
travel
return
variou
geograph
area
may
explain
either
asymptomat
colonis
prolong
nucleic
acid
shed
absenc
viabl
pathogen
also
onset
gastrointestin
symptom
occur
earli
trip
sampl
perform
return
sever
week
later
sampl
time
onset
symptom
perform
futur
studi
respiratori
symptom
mostli
rhiniti
pharyng
affect
medic
student
compar
studi
conduct
medic
student
cohort
australian
travel
return
asia
mostli
tourist
higher
rate
respiratori
symptom
studi
may
result
frequent
contact
student
children
found
signific
associ
viral
carriag
return
persist
respiratori
symptom
associ
found
bacteri
carriag
suggest
respiratori
infect
inde
due
virus
common
viru
acquir
human
rhinoviru
influenza
viru
detect
studi
conduct
among
ill
intern
travel
tropic
subtrop
area
suffer
respiratori
tract
infect
symptom
associ
fever
show
influenza
virus
isol
case
small
number
patient
febril
respiratori
tract
infect
cohort
like
explan
lack
detect
influenza
viru
result
total
femal
student
report
vagin
symptom
acquir
bacteri
vaginosi
base
molecular
quantif
criteria
stay
acquisit
vagina
g
vaginali
detect
femal
student
respect
knowledg
previou
studi
address
preval
vagina
g
vaginali
intern
travel
result
suggest
intern
travel
may
associ
chang
vagin
microbiota
lead
case
clinic
symptom
acquisit
bacteri
vaginosi
may
asymptomat
warrant
investig
larger
number
travel
studi
limit
includ
monocentr
design
small
sampl
size
nevertheless
preliminari
studi
demonstr
besid
well
known
risk
gastrointestin
respiratori
infect
chang
intestin
respiratori
microbiota
medic
student
abroad
like
intern
travel
may
also
experi
chang
vagin
microbiota
vagin
symptom
open
new
research
area
travel
medicin
studi
includ
larger
number
student
need
investig
potenti
risk
factor
clinic
infect
modif
microbiota
despit
student
ask
symptom
overal
exclud
symptom
report
notabl
sexual
transmit
infect
bloodborn
infect
symptom
also
ask
student
sexual
contact
whilst
oversea
note
noninfecti
diseas
risk
address
studi
final
sampl
size
small
address
potenti
effect
destin
symptom
chang
microbiota
trend
toward
studi
abroad
foster
intercultur
exchang
howev
student
higher
exposur
infecti
diseas
although
respiratori
gastrointestin
symptom
selflimit
student
still
symptom
return
could
sourc
infect
famili
member
patient
